Breakwater Capital Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Breakwater Capital Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.11M	Buy	19,656 +2,409	+14%	+$326K	0.37%	68
2026 Q1	$2.2M	Buy	17,247 +476	+3%	+$59.4K	0.3%	77
2025 Q4	$2.04M	Buy	16,771 +1,884	+13%	+$216K	0.29%	84
2025 Q3	$1.49M	Buy	14,887 +3,726	+33%	+$336K	0.22%	103
2025 Q2	$926K	Buy	11,161 +7,068	+173%	+$564K	0.15%	140
2025 Q1	$332K	Sell	4,093 -1,173	-22%	-$105K	0.06%	260
2024 Q4	$474K	Buy	5,266 +744	+16%	+$72.1K	0.09%	187
2024 Q3	$447K	Buy	4,522 +1,185	+36%	+$116K	0.09%	186
2024 Q2	$309K	Buy	3,337 +1,123	+51%	+$101K	0.07%	216
2024 Q1	$210K	Buy	+2,214	New	+$205K	0.05%	252

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Breakwater Capital Group's XBI Position: Q2 2026 in Review

Breakwater Capital Group increased its State Street SPDR S&P Biotech ETF (XBI) stake by 14% in Q2 2026, buying an estimated $326K and bringing the position to 19,656 shares worth $3.11M. The position accounts for 0.37% of the portfolio, ranked #68.

Breakwater Capital Group first reported a position in XBI in Q1 2024 and has held it in 10 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Breakwater Capital Group held 19,656 shares of State Street SPDR S&P Biotech ETF worth $3.11M as of Q2 2026.
Breakwater Capital Group bought 2,409 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $326K.
State Street SPDR S&P Biotech ETF made up 0.37% of Breakwater Capital Group's portfolio in Q2 2026, its #68 holding.
Breakwater Capital Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 10 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Breakwater Capital Group's 13F filing for Q2 2026, filed 8 Jul 2026.